Why have AIM's multiple mRNA vaccines been able to push for FDA approval in such a short time? First, innovation is in AIM's DNA. The mRNA shingles vaccine, currently submitted for U.S. clinical ...
We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we ...
A stark warning has emerged from the medical community concerning a newly discovered coronavirus strain in China, reminiscent of the early days of the COVID-19 pandemic that drastically impacted lives ...